Anti-inflammatory activity of chitosan nanoparticles carrying NF-κB/p65 antisense oligonucleotide in RAW264.7 macropghage stimulated by lipopolysaccharide
Source abstract
Abstract
The purpose of this present study is to prepare NF-κB/p65 antisense oligonucleotide loaded chitosan nanoparticles (NPs) and evaluate their physicochemical characterization and antisense effects in RAW264.7 macrophages. Condensed nanoparticles with mean particle size of 128±16nm, average Zeta potential of 19.6±6.3mV and high entrapment efficiency (EE) of 98.6±0.11% were formed between NF-κB/p65 antisense gene (NAG) and chitosan by complex coacervation method. Trypan blue staining and MTT tests showed that NAG chitosan NPs had no toxic effect on RAW264.7 macrophages when the dose was no more than 20μg/mL. Confocal microscopy images showed that NAG chitosan NPs were capable to deliver NAG into cytoplasm of RAW264.7 macrophages and finally into nucleus. Real-time PCR tests verified that NAG chitosan NPs could significantly decrease the mRNA expression level of NF-κB/p65 and inflammatory cytokines including TNF-ɑ, IL-1 and IL-6. Accordingly, western blot study showed that NAG NPs uptaken in the cells could efficiently reversed the expression of NF-κB/p65 protein induced by LPS. At last, downstream release level of inflammatory factors including TNF-ɑ, IL-1 and IL-6 in LPS stimulated RAW264.7 macrophages was significantly decreased after treated by NAG chitosan NPs. It could be concluded that chitosan NPs were excellent delivery vectors to ferry the NAG into the cytoplasm and nucleus of macrophages. The NAG chitosan NPs might be a novel therapeutic apparatus for the treatment of LPS induced sepsis by inhibiting NF-κB-related pro-inflammatory cytokines secretion.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: NF-κB Signaling Pathways · Immune Response and Inflammation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference10.1097/01.CCM.0000050454.01978.3B ↗
2. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine10.1378/chest.101.6.1644 ↗
3. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis10.1016/j.biomaterials.2015.02.116 ↗
4. Reverse genetic approaches for functional genomics of rice10.1007/s11103-004-4037-y ↗
5. Liposome-coated lipoplex-based carrier for antisense oligonucleotides10.4161/15384047.2014.987009 ↗
6. Recombinant adeno-associated virus BMP-4/7 fusion gene confers ossification activity in rabbit bone marrow stromal cells10.4238/2012.August.31.8 ↗
7. Non-viral vectors for gene-based therapy10.1038/nrg3763 ↗
8. Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies
9. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules10.1016/j.peptides.2014.04.015 ↗
10. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes10.1016/j.biomaterials.2014.04.096 ↗
11. Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference10.1016/j.ijpharm.2014.12.047 ↗
12. Chitosan: a propitious biopolymer for drug delivery10.2174/1567201812666150310151657 ↗
13. Folate-targeted liposome encapsulating chitosan/oligonucleotide polyplexes for tumor targeting10.1208/s12249-014-0136-5 ↗
14. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death10.1126/science.274.5288.782 ↗
15. Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity10.1016/j.ijpharm.2009.12.033 ↗
16. Recombinant adeno-associated virus-, polyethylenimine/plasmid- and lipofectamine/carboxyfluorescein-labeled small interfering RNA-based transfection in retinal pigment epithelial cells with ultrasound and/or SonoVue10.3892/mmr.2015.3219 ↗
17. In vitro and in vivo cytogenotoxic effects of hot aqueous extract of achyrocline satureioides (Lam.) DC10.1155/2015/270973 ↗
18. Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods10.1016/0166-0934(96)02062-9 ↗
19. Anti-inflammatory activity of Saxifragin via inhibition of NF-κB involves Caspase-1 activation10.1021/acs.jnatprod.5b00145 ↗
20. Lotus leaf (Nelumbo nucifera) and its active constituents prevent inflammatory responses in macrophages via JNK/NF-κB signaling pathway10.1142/S0192415X14500554 ↗
21. Anti-inflammatory effects of ethanolic extract from Sargassum horneri (Turner) C. Agardh on lipopolysaccharide-stimulated macrophage activation via NF-κB pathway regulation10.3109/08820139.2014.942459 ↗
22. A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for activator protein-1 hits10.1158/1535-7163.MCT-08-0811 ↗
23. Role of the SOCS in monocytes/macrophages-related pathologies. Are we getting closer to a new pharmacological target?10.1016/S1734-1140(12)70902-7 ↗
24. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells10.1021/mp049970+ ↗
25. Extracellular vesicles as enhancers of virus vector-mediated gene delivery10.1089/hum.2014.082 ↗
26. Chitosan: a novel platform in proton-driven DNA strand rearrangement actuation10.1039/b818982j ↗
27. Magnetic DNA vector constructed from PDMAEMA polycation and PEGylated brush-type polyanion with cross-linkable shell10.1021/la300208n ↗
28. Role of surface charge in cytotoxicity of charged manganese ferrite nanoparticles towards macrophages10.1088/0957-4484/23/50/505702 ↗
29. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis10.1016/S0142-9612(02)00445-3 ↗
30. Elasticity of nanoparticles influences their blood circulation: phagocytosis, endocytosis, and targeting10.1021/acsnano.5b00147 ↗
31. Chitosan NPs as non-viral gene delivery vehicles based on atomic force microscopy study10.1093/abbs/gmp038 ↗
32. Uptake and cytotoxicity of chitosan NPsin human liver cells10.1016/j.taap.2010.08.029 ↗
33. Surface-potential-regulated transmembrane and cytotoxicity of chitosan/gold hybrid nanospheres10.1021/am1001019 ↗